{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T23:27:32Z","timestamp":1786750052841,"version":"build-2736575974"},"reference-count":104,"publisher":"Georg Thieme Verlag KG","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Semin Respir Crit Care Med"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>The COVID-19 disease, presenting with complex immune dysregulation and leading to life-threatening organ dysfunction, represents a paradigm of viral sepsis. As heterogeneity of clinical presentation is contained in COVID-19 (one pathogen, one source of infection) related to bacterial sepsis, and due to the urgency of the pandemic for immediate responsive research networks, many trials have been conducted providing beneficial patient outcomes and changing the natural course of disease. In this review, we summarize lessons learnt from the COVID-19 pandemic related to immunotherapy, management of acute respiratory failure (ARF) and postinfectious sequelae that could be implemented in sepsis care. Biomarker-guided immunotherapy in a tailored, precision medicine approach may alter sepsis outcomes. Measures used during the pandemic to handle ARF, such as high-flow nasal oxygen and awake prone position, have already been incorporated in standard-of-care sepsis management. Last, postinfectious sequelae present equally after sepsis (postsepsis syndrome [PSS]) and COVID-19 (post-COVID-19 syndrome [PCS]); management of PSS may share details from PCS management and vice versa. Teachings from the pandemic are not limited to the above. Overall, the COVID-19 pandemic has transformed global health to a top priority; focus should remain now active on the sepsis agenda.<\/jats:p>","DOI":"10.1055\/a-2933-0145","type":"journal-article","created":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T23:06:31Z","timestamp":1786057591000},"source":"Crossref","is-referenced-by-count":0,"title":["Teachings from the Pandemic"],"prefix":"10.1055","author":[{"given":"Vasileios","family":"Petrakis","sequence":"additional","affiliation":[{"name":"Democritus University of Thrace School of Health Sciences, Makedonia Thraki, Greece","place":["Alexandroupoli"],"department":["2nd Department of Internal Medicine"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dimitrios","family":"Toumpanakis","sequence":"additional","affiliation":[{"name":"Medical School, National and Kapodistrian University of Athens, Attica, Greece","place":["Athens"],"department":["2nd Department of Critical Care Medicine"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9585-517X","authenticated-orcid":false,"given":"Evdoxia","family":"Kyriazopoulou","sequence":"additional","affiliation":[{"name":"School of Nursing, National and Kapodistrian University of Athens, Attica, Greece","place":["Athens"],"department":["Department of Critical Care"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"194","published-online":{"date-parts":[[2026,8,14]]},"reference":[{"issue":"08","key":"ref1","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1001\/jama.2016.0287","article-title":"The Third International Consensus definitions for sepsis and septic shock (Sepsis-3)","volume":"315","author":"M Singer","year":"2016","journal-title":"JAMA"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/S0140-6736(19)32989-7","article-title":"Global, regional, and national sepsis incidence and mortality, 1990-2017: analysis for the Global Burden of Disease Study","volume":"395","author":"K E Rudd","year":"2020","journal-title":"Lancet"},{"issue":"12","key":"ref4","doi-asserted-by":"crossref","first-page":"2042","DOI":"10.1097\/CCM.0000000000005195","article-title":"Coronavirus disease 2019 as cause of viral sepsis: a systematic review and meta-analysis","volume":"49","author":"E Karakike","year":"2021","journal-title":"Crit Care Med"},{"issue":"01","key":"ref5","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1186\/s13054-024-04964-6","article-title":"Towards personalized medicine: a scoping review of immunotherapy in sepsis","volume":"28","author":"M A Slim","year":"2024","journal-title":"Crit Care"},{"issue":"08","key":"ref6","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1056\/NEJMoa2021436","article-title":"Dexamethasone in hospitalized patients with COVID-19","volume":"384","author":"P Horby","year":"2021","journal-title":"N Engl J Med"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1016\/S0140-6736(21)00676-0","article-title":"Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial","volume":"397","author":"RECOVERY Collaborative Group","year":"2021","journal-title":"Lancet"},{"issue":"16","key":"ref8","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1056\/NEJMoa2100433","article-title":"Interleukin-6 receptor antagonists in critically ill patients with COVID-19","volume":"384","author":"A C Gordon","year":"2021","journal-title":"N Engl J Med"},{"issue":"10","key":"ref9","doi-asserted-by":"crossref","first-page":"1752","DOI":"10.1038\/s41591-021-01499-z","article-title":"Early treatment of COVID-19 with anakinra guided by soluble urokinase plasminogen receptor plasma levels: a double-blind, randomized controlled phase 3 trial","volume":"27","author":"E Kyriazopoulou","year":"2021","journal-title":"Nat Med"},{"issue":"01","key":"ref10","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1164\/rccm.202010-4023LE","article-title":"What sepsis researchers can learn from COVID-19","volume":"203","author":"M Schinkel","year":"2021","journal-title":"Am J Respir Crit Care Med"},{"issue":"06","key":"ref11","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1016\/j.chom.2020.04.009","article-title":"Complex immune dysregulation in COVID-19 patients with severe respiratory failure","volume":"27","author":"E J Giamarellos-Bourboulis","year":"2020","journal-title":"Cell Host Microbe"},{"issue":"12","key":"ref12","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1016\/S2213-2600(20)30404-5","article-title":"Cytokine elevation in severe and critical COVID-19: a rapid systematic review, meta-analysis, and comparison with other inflammatory syndromes","volume":"8","author":"D E Leisman","year":"2020","journal-title":"Lancet Respir Med"},{"issue":"10","key":"ref13","doi-asserted-by":"crossref","first-page":"2620","DOI":"10.3390\/biomedicines10102620","article-title":"From cytokine storm to cytokine breeze: did lessons learned from immunopathogenesis improve immunomodulatory treatment of moderate-to-severe COVID-19?","volume":"10","author":"G Rondovic","year":"2022","journal-title":"Biomedicines"},{"issue":"7865","key":"ref14","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1038\/s41586-021-03569-1","article-title":"A molecular single-cell lung atlas of lethal COVID-19","volume":"595","author":"J C Melms","year":"2021","journal-title":"Nature"},{"issue":"7860","key":"ref15","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1038\/s41586-021-03475-6","article-title":"The spatial landscape of lung pathology during COVID-19 progression","volume":"593","author":"A F Rendeiro","year":"2021","journal-title":"Nature"},{"issue":"01","key":"ref16","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1186\/s12967-020-02646-9","article-title":"The dysregulated innate immune response in severe COVID-19 pneumonia that could drive poorer outcome","volume":"18","author":"M Blot","year":"2020","journal-title":"J Transl Med"},{"issue":"10","key":"ref17","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1016\/S2213-2600(20)30217-4","article-title":"Immunotherapies for COVID-19: lessons learned from sepsis","volume":"8","author":"K E Remy","year":"2020","journal-title":"Lancet Respir Med"},{"issue":"07","key":"ref18","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1038\/nri.2017.36","article-title":"The immunopathology of sepsis and potential therapeutic targets","volume":"17","author":"T van der Poll","year":"2017","journal-title":"Nat Rev Immunol"},{"issue":"01","key":"ref19","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1038\/s41590-023-01660-5","article-title":"The pathophysiology of sepsis and precision-medicine-based immunotherapy","volume":"25","author":"E J Giamarellos-Bourboulis","year":"2024","journal-title":"Nat Immunol"},{"issue":"01","key":"ref20","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1038\/s41581-019-0199-3","article-title":"Prognostic and predictive enrichment in sepsis","volume":"16","author":"N L Stanski","year":"2020","journal-title":"Nat Rev Nephrol"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.3389\/fimmu.2020.01636","article-title":"Immune and metabolic signatures of COVID-19 revealed by transcriptomics data reuse","volume":"11","author":"L G Gardinassi","year":"2020","journal-title":"Front Immunol"},{"issue":"S 02","key":"ref24","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1007\/s00063-023-01089-6","article-title":"Adjunctive treatment in COVID-19 and sepsis-what did we learn?","volume":"118","author":"E J Giamarellos-Bourboulis","year":"2023","journal-title":"Med Klin Intensivmed Notfmed"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"101573","DOI":"10.1016\/j.lanepe.2025.101573","article-title":"Efficacy of anakinra in reducing progression to organ dysfunction in patients with pneumonia (INSPIRE): a randomised, double-blind, placebo-controlled, phase IIa trial","volume":"62","author":"G Tavoulareas","year":"2025","journal-title":"Lancet Reg Health Eur"},{"issue":"09","key":"ref26","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1001\/jama.2025.24175","article-title":"Precision immunotherapy to improve sepsis outcomes: the ImmunoSep randomized clinical trial","volume":"335","author":"E J Giamarellos-Bourboulis","year":"2026","journal-title":"JAMA"},{"issue":"11","key":"ref27","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1080\/14737159.2023.2258063","article-title":"Biomarkers to guide immunomodulatory treatment: where do we stand?","volume":"23","author":"E Kyriazopoulou","year":"2023","journal-title":"Expert Rev Mol Diagn"},{"issue":"01","key":"ref28","doi-asserted-by":"crossref","first-page":"28","DOI":"10.3390\/jpm16010028","article-title":"Artificial intelligence- and machine learning-assisted subphenotyping for personalized immunotherapy in sepsis","volume":"16","author":"E Kyriazopoulou","year":"2026","journal-title":"J Pers Med"},{"issue":"04","key":"ref29","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/S2213-2600(23)00468-X","article-title":"Reframing sepsis immunobiology for translation: towards informative subtyping and targeted immunomodulatory therapies","volume":"12","author":"M Shankar-Hari","year":"2024","journal-title":"Lancet Respir Med"},{"issue":"12","key":"ref30","doi-asserted-by":"crossref","first-page":"4084","DOI":"10.1038\/s41591-025-03956-5","article-title":"A consensus immune dysregulation framework for sepsis and critical illnesses","volume":"31","author":"A R Moore","year":"2025","journal-title":"Nat Med"},{"issue":"02","key":"ref31","doi-asserted-by":"crossref","first-page":"e170","DOI":"10.1097\/CCM.0000000000004786","article-title":"Validation of inflammopathic, adaptive, and coagulopathic sepsis endotypes in coronavirus disease 2019","volume":"49","author":"T E Sweeney","year":"2021","journal-title":"Crit Care Med"},{"issue":"01","key":"ref32","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1186\/s13054-024-04852-z","article-title":"Transitions of blood immune endotypes and improved outcome by anakinra in COVID-19 pneumonia: an analysis of the SAVE-MORE randomized controlled trial","volume":"28","author":"E Kyriazopoulou","year":"2024","journal-title":"Crit Care"},{"issue":"01","key":"ref33","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1007\/s00134-025-08218-z","article-title":"Temporal robustness of biomarker-based classification algorithms for sepsis","volume":"52","author":"E Rademaker","year":"2026","journal-title":"Intensive Care Med"},{"key":"ref35","volume-title":"Platform Randomised Trial of Treatments in the Community for Epidemic and Pandemic Illnesses (PRINCIPLE)"},{"key":"ref36","volume-title":"Randomised Evaluation of COVID-19 Therapy (RECOVERY)"},{"key":"ref37","volume-title":"About REMAP-CAP"},{"issue":"05","key":"ref38","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1016\/S0025-7125(16)32228-3","article-title":"Corticosteroids and infectious diseases","volume":"57","author":"D C Dale","year":"1973","journal-title":"Med Clin North Am"},{"issue":"22","key":"ref39","doi-asserted-by":"crossref","first-page":"2362","DOI":"10.1001\/jama.2009.815","article-title":"Corticosteroids in the treatment of severe sepsis and septic shock in adults: a systematic review","volume":"301","author":"D Annane","year":"2009","journal-title":"JAMA"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/S0140-6736(20)30317-2","article-title":"Clinical evidence does not support corticosteroid treatment for 2019-nCoV lung injury","volume":"395","author":"C D Russell","year":"2020","journal-title":"Lancet"},{"issue":"13","key":"ref41","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1001\/jama.2020.17022","article-title":"Effect of hydrocortisone on mortality and organ support in patients with severe COVID-19: the REMAP-CAP COVID-19 corticosteroid domain randomized clinical trial","volume":"324","author":"D C Angus","year":"2020","journal-title":"JAMA"},{"issue":"04","key":"ref42","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1007\/s00134-025-07861-w","article-title":"Effect of hydrocortisone on mortality in patients with severe community-acquired pneumonia: the REMAP-CAP Corticosteroid Domain Randomized Clinical Trial","volume":"51","author":"D C Angus","year":"2025","journal-title":"Intensive Care Med"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"e192","DOI":"10.1016\/S1473-3099(20)30483-7","article-title":"Group on the clinical characterisation and management of COVID-19 infection. A minimal common outcome measure set for COVID-19 clinical research","volume":"20","author":"W HO Working","year":"2020","journal-title":"Lancet Infect Dis"},{"issue":"01","key":"ref44","doi-asserted-by":"crossref","first-page":"230035","DOI":"10.1183\/20734735.0035-2023","article-title":"Lessons from COVID-19 in the management of acute respiratory failure","volume":"19","author":"C Crimi","year":"2023","journal-title":"Breathe (Sheff)"},{"issue":"07","key":"ref45","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1007\/s00134-023-07050-7","article-title":"ESICM guidelines on acute respiratory distress syndrome: definition, phenotyping and respiratory support strategies","volume":"49","author":"G Grasselli","year":"2023","journal-title":"Intensive Care Med"},{"issue":"01","key":"ref46","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1164\/rccm.202303-0558WS","article-title":"A new global definition of acute respiratory distress syndrome","volume":"209","author":"M A Matthay","year":"2024","journal-title":"Am J Respir Crit Care Med"},{"issue":"01","key":"ref47","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1164\/rccm.202311-2011ST","article-title":"An update on management of adult patients with acute respiratory distress syndrome: an official American Thoracic Society Clinical Practice guideline","volume":"209","author":"N Qadir","year":"2024","journal-title":"Am J Respir Crit Care Med"},{"issue":"04","key":"ref48","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1097\/CCM.0000000000007089","article-title":"Surviving Sepsis Campaign: international guidelines for management of sepsis and septic shock 2026","volume":"54","author":"H C Prescott","year":"2026","journal-title":"Crit Care Med"},{"issue":"01","key":"ref49","doi-asserted-by":"crossref","first-page":"00196-2022","DOI":"10.1183\/23120541.00196-2022","article-title":"The use of lung ultrasound in COVID-19","volume":"9","author":"I Blazic","year":"2023","journal-title":"ERJ Open Res"},{"issue":"04","key":"ref50","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1007\/s00134-021-06373-7","article-title":"Lung ultrasound for the early diagnosis of COVID-19 pneumonia: an international multicenter study","volume":"47","author":"G Volpicelli","year":"2021","journal-title":"Intensive Care Med"},{"issue":"10","key":"ref51","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1016\/j.acra.2020.07.002","article-title":"Semiquantitative lung ultrasound scores in the evaluation and follow-up of critically ill patients with COVID-19: a single-center study","volume":"27","author":"Q Deng","year":"2020","journal-title":"Acad Radiol"},{"issue":"10","key":"ref52","doi-asserted-by":"crossref","first-page":"1873","DOI":"10.1007\/s00134-020-06212-1","article-title":"Lung ultrasound predicts clinical course and outcomes in COVID-19 patients","volume":"46","author":"Y Lichter","year":"2020","journal-title":"Intensive Care Med"},{"issue":"09","key":"ref53","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1007\/s00134-020-06186-0","article-title":"Comparative study of lung ultrasound and chest computed tomography scan in the assessment of severity of confirmed COVID-19 pneumonia","volume":"46","author":"L Zieleskiewicz","year":"2020","journal-title":"Intensive Care Med"},{"key":"ref54","doi-asserted-by":"crossref","first-page":"1","DOI":"10.18332\/pne\/185364","article-title":"The utility of lung ultrasound in COVID-19 pneumonia in the intensive care unit in real life settings","volume":"37","author":"D Toumpanakis","year":"2024","journal-title":"Pneumon (Athens)"},{"issue":"09","key":"ref55","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1164\/rccm.201701-0006ED","article-title":"Not just oxygen? Mechanisms of benefit from high-flow nasal cannula in hypoxemic respiratory failure","volume":"195","author":"E C Goligher","year":"2017","journal-title":"Am J Respir Crit Care Med"},{"issue":"23","key":"ref56","doi-asserted-by":"crossref","first-page":"2185","DOI":"10.1056\/NEJMoa1503326","article-title":"High-flow oxygen through nasal cannula in acute hypoxemic respiratory failure","volume":"372","author":"J P Frat","year":"2015","journal-title":"N Engl J Med"},{"issue":"12","key":"ref57","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1001\/jama.2022.15613","article-title":"Effect of high-flow nasal cannula oxygen vs standard oxygen therapy on mortality in patients with respiratory failure due to COVID-19: the SOHO-COVID randomized clinical trial","volume":"328","author":"J P Frat","year":"2022","journal-title":"JAMA"},{"issue":"06","key":"ref58","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1001\/jama.2022.0028","article-title":"Effect of noninvasive respiratory strategies on intubation or mortality among patients with acute hypoxemic respiratory failure and COVID-19: the RECOVERY-RS randomized clinical trial","volume":"327","author":"G D Perkins","year":"2022","journal-title":"JAMA"},{"issue":"04","key":"ref59","doi-asserted-by":"crossref","first-page":"2101574","DOI":"10.1183\/13993003.01574-2021","article-title":"ERS clinical practice guidelines: high-flow nasal cannula in acute respiratory failure","volume":"59","author":"S Oczkowski","year":"2022","journal-title":"Eur Respir J"},{"issue":"04","key":"ref60","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1007\/s00134-025-07890-5","article-title":"Outcomes in immunocompromised patients with acute hypoxemic respiratory failure treated by high-flow nasal oxygen","volume":"51","author":"E Azoulay","year":"2025","journal-title":"Intensive Care Med"},{"issue":"10","key":"ref61","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1001\/jama.2024.26244","article-title":"High-flow nasal oxygen vs noninvasive ventilation in patients with acute respiratory failure: the RENOVATE randomized clinical trial","volume":"333","author":"I S Maia","year":"2025","journal-title":"JAMA"},{"issue":"04","key":"ref62","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1016\/j.chest.2023.04.022","article-title":"Noninvasive oxygenation strategies in adult patients with acute hypoxemic respiratory failure: a systematic review and network meta-analysis","volume":"164","author":"T Pitre","year":"2023","journal-title":"Chest"},{"issue":"02","key":"ref63","doi-asserted-by":"crossref","first-page":"1602426","DOI":"10.1183\/13993003.02426-2016","article-title":"Official ERS\/ATS clinical practice guidelines: noninvasive ventilation for acute respiratory failure","volume":"50","author":"B Rochwerg","year":"2017","journal-title":"Eur Respir J"},{"issue":"08","key":"ref64","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1016\/S2213-2600(24)00118-8","article-title":"When to intubate in acute hypoxaemic respiratory failure? Options and opportunities for evidence-informed decision making in the intensive care unit","volume":"12","author":"K G Lee","year":"2024","journal-title":"Lancet Respir Med"},{"key":"ref65","doi-asserted-by":"crossref","first-page":"100954","DOI":"10.1016\/j.lanepe.2024.100954","article-title":"In-hospital mortality, comorbidities, and costs of one million mechanically ventilated patients in Germany: a nationwide observational study before, during, and after the COVID-19 pandemic","volume":"42","author":"C Karagiannidis","year":"2024","journal-title":"Lancet Reg Health Eur"},{"issue":"12","key":"ref66","doi-asserted-by":"crossref","first-page":"2238","DOI":"10.1007\/s00134-020-06228-7","article-title":"Use of nasal high flow oxygen during acute respiratory failure","volume":"46","author":"J D Ricard","year":"2020","journal-title":"Intensive Care Med"},{"issue":"23","key":"ref67","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.1056\/NEJMoa1214103","article-title":"Prone positioning in severe acute respiratory distress syndrome","volume":"368","author":"C Gu\u00e9rin","year":"2013","journal-title":"N Engl J Med"},{"key":"ref68","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.thromres.2018.12.003","article-title":"Low D-dimer levels in sepsis: good or bad?","volume":"174","author":"F Semeraro","year":"2019","journal-title":"Thromb Res"},{"issue":"21","key":"ref69","doi-asserted-by":"crossref","first-page":"2104","DOI":"10.1001\/jama.2022.7993","article-title":"Effect of awake prone positioning on endotracheal intubation in patients with COVID-19 and acute respiratory failure: a randomized clinical trial","volume":"327","author":"W Alhazzani","year":"2022","journal-title":"JAMA"},{"issue":"12","key":"ref70","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1016\/S2213-2600(21)00356-8","article-title":"Awake prone positioning for COVID-19 acute hypoxaemic respiratory failure: a randomised, controlled, multinational, open-label meta-trial","volume":"9","author":"S Ehrmann","year":"2021","journal-title":"Lancet Respir Med"},{"issue":"168","key":"ref71","doi-asserted-by":"crossref","first-page":"220245","DOI":"10.1183\/16000617.0245-2022","article-title":"Awake prone positioning in acute hypoxaemic respiratory failure","volume":"32","author":"B A McNicholas","year":"2023","journal-title":"Eur Respir Rev"},{"issue":"04","key":"ref73","doi-asserted-by":"crossref","first-page":"e102","DOI":"10.1016\/S1473-3099(21)00703-9","article-title":"A clinical case definition of post-COVID-19 condition by a Delphi consensus","volume":"22","author":"J B Soriano","year":"2022","journal-title":"Lancet Infect Dis"},{"issue":"18","key":"ref74","doi-asserted-by":"crossref","first-page":"1746","DOI":"10.1056\/NEJMsb2408466","article-title":"Long covid defined","volume":"391","author":"E W Ely","year":"2024","journal-title":"N Engl J Med"},{"issue":"16","key":"ref75","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.1001\/jama.2022.18931","article-title":"Estimated global proportions of individuals with persistent fatigue, cognitive, and respiratory symptom clusters following symptomatic COVID-19 in 2020 and 2021","volume":"328","author":"S Wulf Hanson","year":"2022","journal-title":"JAMA"},{"issue":"03","key":"ref76","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/j.cmi.2023.10.016","article-title":"Prevalence and risk factors for persistent symptoms after COVID-19: a systematic review and meta-analysis","volume":"30","author":"D Luo","year":"2024","journal-title":"Clin Microbiol Infect"},{"key":"ref80","doi-asserted-by":"crossref","first-page":"102251","DOI":"10.1016\/j.eclinm.2023.102251","article-title":"Long-term symptom profiles after COVID-19 vs other acute respiratory infections: an analysis of data from the COVIDENCE UK study","volume":"65","author":"G Vivaldi","year":"2023","journal-title":"EClinicalMedicine"},{"issue":"01","key":"ref81","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/s10020-019-0132-z","article-title":"Post-sepsis syndrome - an evolving entity that afflicts survivors of sepsis","volume":"26","author":"Z Mostel","year":"2019","journal-title":"Mol Med"},{"issue":"01","key":"ref82","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1186\/s13054-024-05076-x","article-title":"How are long-COVID, post-sepsis-syndrome and post-intensive-care-syndrome related? A conceptional approach based on the current research literature","volume":"28","author":"C Fleischmann-Struzek","year":"2024","journal-title":"Crit Care"},{"key":"ref83","doi-asserted-by":"crossref","first-page":"6493","DOI":"10.2147\/IDR.S390947","article-title":"Understanding post-sepsis syndrome: how can clinicians help?","volume":"16","author":"E C van der Slikke","year":"2023","journal-title":"Infect Drug Resist"},{"issue":"02","key":"ref84","doi-asserted-by":"crossref","first-page":"R70","DOI":"10.1186\/cc12616","article-title":"Mortality and quality of life in the five years after severe sepsis","volume":"17","author":"B H Cuthbertson","year":"2013","journal-title":"Crit Care"},{"issue":"03","key":"ref85","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1007\/s15010-021-01733-3","article-title":"Comparison of fatigue, cognitive dysfunction and psychological disorders in post-COVID patients and patients after sepsis: is there a specific constellation?","volume":"50","author":"A Stallmach","year":"2022","journal-title":"Infection"},{"issue":"03","key":"ref87","doi-asserted-by":"crossref","first-page":"e043352","DOI":"10.1136\/bmjopen-2020-043352","article-title":"Mid-German sepsis cohort (MSC): a prospective observational study of sepsis survivorship","volume":"11","author":"C Fleischmann-Struzek","year":"2021","journal-title":"BMJ Open"},{"issue":"02","key":"ref88","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1164\/rccm.201510-2023OC","article-title":"Long-term mortality and major adverse cardiovascular events in sepsis survivors. A nationwide population-based study","volume":"194","author":"S M Ou","year":"2016","journal-title":"Am J Respir Crit Care Med"},{"issue":"10","key":"ref89","doi-asserted-by":"crossref","first-page":"2211","DOI":"10.1097\/CCM.0000000000000503","article-title":"Long-term (10-year) mortality of younger previously healthy patients with severe sepsis\/septic shock is worse than that of patients with nonseptic critical illness and of the general population","volume":"42","author":"A Linder","year":"2014","journal-title":"Crit Care Med"},{"issue":"08","key":"ref90","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1007\/s00406-023-01661-3","article-title":"Longterm course of neuropsychological symptoms and ME\/CFS after SARS-CoV-2-infection: a prospective registry study","volume":"274","author":"P A Reuken","year":"2024","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"issue":"05","key":"ref91","doi-asserted-by":"crossref","first-page":"103211","DOI":"10.1016\/j.jiph.2026.103211","article-title":"Long-term prognosis of sepsis survivors after hospital discharge: A systematic review and meta-analysis of observational studies","volume":"19","author":"S Lei","year":"2026","journal-title":"J Infect Public Health"},{"issue":"01","key":"ref92","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1093\/bmb\/ldad016","article-title":"Long COVID: what is known and what gaps need to be addressed","volume":"147","author":"B Krishna","year":"2023","journal-title":"Br Med Bull"},{"key":"ref93","doi-asserted-by":"crossref","first-page":"698169","DOI":"10.3389\/fmicb.2021.698169","article-title":"Long COVID or post-acute sequelae of COVID-19 (PASC): an overview of biological factors that may contribute to persistent symptoms","volume":"12","author":"A D Proal","year":"2021","journal-title":"Front Microbiol"},{"issue":"02","key":"ref94","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1097\/CCM.0000000000002074","article-title":"Sepsis pathophysiology, chronic critical illness, and persistent inflammation-immunosuppression and catabolism syndrome","volume":"45","author":"J C Mira","year":"2017","journal-title":"Crit Care Med"},{"issue":"01","key":"ref95","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/s13054-017-1934-4","article-title":"Protracted immune disorders at one year after ICU discharge in patients with septic shock","volume":"22","author":"F Rich\u00e9","year":"2018","journal-title":"Crit Care"},{"issue":"08","key":"ref96","doi-asserted-by":"crossref","first-page":"e198686","DOI":"10.1001\/jamanetworkopen.2019.8686","article-title":"Long-term host immune response trajectories among hospitalized patients with sepsis","volume":"2","author":"S Yende","year":"2019","journal-title":"JAMA Netw Open"},{"key":"ref97","doi-asserted-by":"crossref","first-page":"110656","DOI":"10.1016\/j.clim.2025.110656","article-title":"Long-term immune and epigenetic dysregulation following COVID-19","volume":"283","author":"C Sidiropoulou","year":"2026","journal-title":"Clin Immunol"},{"issue":"01","key":"ref98","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1001\/jama.2022.23257","article-title":"Long-term (180-Day) outcomes in critically ill patients with COVID-19 in the REMAP-CAP randomized clinical trial","volume":"329","author":"A M Higgins","year":"2023","journal-title":"JAMA"},{"key":"ref99","first-page":"101064","article-title":"Long-term effect of tocilizumab on mortality, readmissions, persistent symptoms and lung function in SARS-CoV-2 patients 1 year after hospital discharge: a matched cohort study","volume":"84","author":"I Cardona-Pascual","year":"2023","journal-title":"Respir Med Res"},{"key":"ref100","doi-asserted-by":"crossref","first-page":"100513","DOI":"10.1016\/j.bbih.2022.100513","article-title":"Long-term cognitive performance and its relation to anti-inflammatory therapy in a cohort of survivors of severe COVID-19","volume":"25","author":"H B Duindam","year":"2022","journal-title":"Brain Behav Immun Health"},{"issue":"12","key":"ref101","doi-asserted-by":"crossref","first-page":"4158","DOI":"10.3390\/jcm12124158","article-title":"Treatment of COVID-19 during the acute phase in hospitalized patients decreases post-acute sequelae of COVID-19","volume":"12","author":"D Badenes Bonet","year":"2023","journal-title":"J Clin Med"},{"key":"ref102","doi-asserted-by":"crossref","first-page":"101785","DOI":"10.1016\/j.eclinm.2022.101785","article-title":"Efficacy and safety of early soluble urokinase plasminogen receptor plasma-guided anakinra treatment of COVID-19 pneumonia: a subgroup analysis of the SAVE-MORE randomised trial","volume":"56","author":"K Akinosoglou","year":"2023","journal-title":"EClinicalMedicine"},{"issue":"10","key":"ref104","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1016\/S1473-3099(23)00299-2","article-title":"Outpatient treatment of COVID-19 and incidence of post-COVID-19 condition over 10 months (COVID-OUT): a multicentre, randomised, quadruple-blind, parallel-group, phase 3 trial","volume":"23","author":"C T Bramante","year":"2023","journal-title":"Lancet Infect Dis"},{"issue":"07","key":"ref105","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1016\/j.cmi.2022.02.018","article-title":"ESCMID rapid guidelines for assessment and management of long COVID","volume":"28","author":"D Yelin","year":"2022","journal-title":"Clin Microbiol Infect"},{"issue":"02","key":"ref106","doi-asserted-by":"crossref","first-page":"2102174","DOI":"10.1183\/13993003.02174-2021","article-title":"European Respiratory Society statement on long COVID follow-up","volume":"60","author":"K M Antoniou","year":"2022","journal-title":"Eur Respir J"},{"issue":"7922","key":"ref107","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1038\/d41586-022-02140-w","article-title":"Long-COVID treatments: why the world is still waiting","volume":"608","author":"H Ledford","year":"2022","journal-title":"Nature"},{"issue":"05","key":"ref108","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1513\/AnnalsATS.202008-1002OC","article-title":"Persistent post-COVID-19 interstitial lung disease. An observational study of corticosteroid treatment","volume":"18","author":"K J Myall","year":"2021","journal-title":"Ann Am Thorac Soc"},{"key":"ref109","doi-asserted-by":"crossref","first-page":"107105","DOI":"10.1016\/j.ijid.2024.107105","article-title":"The global clinical studies of long COVID","volume":"146","author":"D Ramonfaur","year":"2024","journal-title":"Int J Infect Dis"},{"issue":"05","key":"ref110","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1016\/j.jamda.2023.02.009","article-title":"Passing the SNF test: a secondary analysis of a sepsis transition intervention trial among patients discharged to post-acute care","volume":"24","author":"N A Colucciello","year":"2023","journal-title":"J Am Med Dir Assoc"},{"issue":"03","key":"ref111","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.amjmed.2019.08.033","article-title":"Long-term courses of sepsis survivors: effects of a primary care management intervention","volume":"133","author":"K F Schmidt","year":"2020","journal-title":"Am J Med"},{"key":"ref112","doi-asserted-by":"crossref","first-page":"105075","DOI":"10.1016\/j.healthpol.2024.105075","article-title":"Lessons learned from a global analysis of priority setting practices in pandemic response planning","volume":"144","author":"L Kapiriri","year":"2024","journal-title":"Health Policy"},{"issue":"07","key":"ref113","doi-asserted-by":"crossref","first-page":"e2220385","DOI":"10.1001\/jamanetworkopen.2022.20385","article-title":"Estimated number of COVID-19 infections, hospitalizations, and deaths prevented among vaccinated persons in the US, December 2020 to September 2021","volume":"5","author":"M K Steele","year":"2022","journal-title":"JAMA Netw Open"},{"issue":"03","key":"ref114","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/S1473-3099(21)00566-1","article-title":"Infections, hospitalisations, and deaths averted via a nationwide vaccination campaign using the Pfizer-BioNTech BNT162b2 mRNA COVID-19 vaccine in Israel: a retrospective surveillance study","volume":"22","author":"E J Haas","year":"2022","journal-title":"Lancet Infect Dis"}],"container-title":["Seminars in Respiratory and Critical Care Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.thieme-connect.de\/products\/ejournals\/pdf\/10.1055\/a-2933-0145.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T23:10:49Z","timestamp":1786749049000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.thieme-connect.de\/DOI\/DOI?10.1055\/a-2933-0145"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,6]]},"references-count":104,"URL":"https:\/\/doi.org\/10.1055\/a-2933-0145","archive":["Portico","CLOCKSS"],"relation":{},"ISSN":["1069-3424","1098-9048"],"issn-type":[{"value":"1069-3424","type":"print"},{"value":"1098-9048","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,8,6]]},"published":{"date-parts":[[2026,8,6]]}}}